PR Newswire

Delscience
Nanomedicine and Drug Delivery News
Filter     Order     Display # 
Date Item Title
Wednesday, 23 February 2011 Delcath Systems receives refusal to file letter from FDA
Tuesday, 22 February 2011 Versartis completes USD 21 million Series B financing
Thursday, 17 February 2011 TransPharma Announces completion of a Phase 1b trial of ViaDor-GLP1 agonist
Thursday, 17 February 2011 Boston Scientific launches PROMUS® Element and TAXUS® Element stent systems in India
Wednesday, 09 February 2011 QLT reports phase II trial results for olopatadine punctal plug delivery system
Thursday, 03 February 2011 Marina Biotech and The Debiopharm Group partner to develop and commercialize RNAi-Based therapies
Monday, 31 January 2011 Cancer-targeting investigational nanoparticle receives FDA IND approval
Tuesday, 18 January 2011 Alexza Pharmaceuticals completes End-of-Review Meeting with FDA for AZ-004
Tuesday, 18 January 2011 Arrowhead Research Corporation investment announcement
Monday, 17 January 2011 Diamyd starts Phase II study in cancer pain
Monday, 17 January 2011 Micell Technologies enrolls first patient in study of MiStent DES
Wednesday, 12 January 2011 Dance Pharma and Aerogen to develop proprietary inhaled insulin device
Monday, 10 January 2011 Celator Pharmaceuticals and Cephalon agree to extend research agreement
Monday, 10 January 2011 New oral biologics delivery company, Entrega
Friday, 07 January 2011 BIND Biosciences initiates Phase I clinical study of BIND-014
Thursday, 06 January 2011 Generex and RXi Pharmaceuticals announce positive data using RNAi technology
Tuesday, 04 January 2011 MonoSol and Midatech complete transbuccal insulin delivery study in primates
Tuesday, 04 January 2011 Santaris Pharma announces expanded strategic alliance with Pfizer
 
<< Start < Prev 1 Next > End >>
Results 1 - 18 of 18


FAQ . Copyright 2010. Sitemap . Privacy policy